Fa
فارسی
En
English/Iran Health Center Inc.
Home
About
Vision
Mission
Services
Payments
Contact Us
WHO Org:
more read ...
WHO and partners rally cervical cancer elimination efforts
As world leaders arrive in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the city’s iconic Christ the Redeemer statue will be illuminated in the colour teal. The Brazilian advocates behind this effort are among many around the globe joining the World Health Organization (WHO) to mobilize efforts on a worldwide “Day of Action for Cervical Cancer Elimination.” Other countries are marking the day with campaigns to provide human papillomavirus (HPV) vaccination and screening, launching new health policies to align with the world’s first-ever effort to eliminate a cancer, and raising awareness in communities.
11/17/2024 7:23:44 PM
Related Topics
WHO Org:
more ...
WHO in Lebanon working to stop cholera spread amid conflict
On 16 October, the Ministry of Public Health of Lebanon confirmed a cholera case, highlighting the escalating health risks amidst ongoing conflict. The case was identified in Akkar governorate in the north of the country, marking the first case since the October 2022-June 2023 outbreak was declared over. Authorities are investigating the extent of the disease’s spread, gathering samples from the patient’s contacts, and assessing potential water contamination.
PAHO Org:
more ...
PAHO issues update on Oropouche fever
Washington, DC, October 16, 2024 (PAHO) – The Pan American Health Organization (PAHO) has issued an epidemiological update on Oropouche virus disease (OROV), highlighting the importance of strengthening diagnosis, clinical management, prevention, and vector control measures in the Americas region.Since the beginning of the year to early October,…
WHO Org:
more ...
WHO approves first mpox diagnostic test for emergency use, boosting global access
The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing. The approval for emergency use of the Alinity m MPXV assay, manufactured by Abbott Molecular Inc., will be pivotal in expanding diagnostic capacity in countries facing mpox outbreaks, where the need for quick and accurate testing has risen sharply. Early diagnosis of mpox enables timely treatment and care, and control of the virus.